Connect with us

News

RJ Scaringe has raised more than $12 billion across three startups and investors still want more

info

Published

on

Rj scaringe.jpeg

Investors can’t seem to get enough of RJ Scaringe or his ideas.

In less than a decade, the serial entrepreneur best known for his EV company Rivian, has raised more than $12.3 billion from venture capital firms, as well as strategic and institutional investors for his three — and counting — startups. If the latest $400 million raise for his new venture Mind Robotics is an indicator, investors are still happily piling in.

Outsized raises for newly minted startups have become more common in recent years. But those hundred-million-plus seed rounds have generally been reserved for buzzy defense tech startups or AI companies founded by former OpenAI or Anthropic employees.

Those supersized seeds certainly weren’t flowing toward something as niche as an electric micromobility startup. And yet in 2025, Scaringe raised $105 million for exactly that — a startup called Also, which he founded that same year. The total has since surpassed $300 million, with DoorDash among its backers.

Jiten Behl, partner at Eclipse and former chief growth officer at Rivian, has spent years watching and learning from Scaringe. His firm is now one of Scaringe’s biggest backers, leading rounds in both Also and Mind Robotics — Scaringe’s industrial AI and robotics startup that he also founded last year.

Storytelling and communication are one of his superpowers, according to Behl, who joined Rivian when the company had just a handful of employees.

“When RJ explains a certain issue, topic, opportunity, vision, he just has this very unique ability to communicate it so effectively, and it comes across so credible,” Behl said. “He’s not trying to undersell the difficulty or oversell the opportunity, and that’s an art.”

Scaringe isn’t the only serial entrepreneur to repeatedly attract massive amounts of capital, but founders who can raise billions across multiple ventures remain rare. A self-professed car enthusiast who earned his doctorate in mechanical engineering from MIT, Scaringe joins a small cadre of entrepreneurs that includes Tesla CEO and SpaceX co-founder Elon Musk, OpenAI CEO Sam Altman, Anduril and Oculus founder Palmer Luckey, and Jack Dorsey, who founded Square (now called Block) and Twitter.

The difference, at least in the view of some investors TechCrunch spoke to, is that he is able to separate selling the idea from selling himself. “He is very comfortable and confident in his own personality, and he’s not trying to be an Elon,” Behl said, noting that many have tried to make the comparison over the years.

“It’s not about him,” another insider familiar with Scaringe’s companies told TechCrunch. “When you talk to him, he has enthusiasm about the product that is completely external.”

Of course, there is confidence and even a little ego, the same source mused, but “it doesn’t weigh on you.” The source also added that Scaringe also has a unique ability to make you feel like the most special person in the room — a sentiment others echoed.

Giving that kind of undivided attention to an investor, supplier, or exec at a manufacturer is a challenge at the scale Scaringe is attempting. He is running three companies, often traveling between Palo Alto, Irvine, Rivian’s factory in Normal, Illinois, and a second factory soon to open in Georgia. And then there is family — Scaringe has three sons with his ex-wife.

Joe Fath, another partner at Eclipse, credits his open-mindedness and collaborative nature for helping him attract investment and juggle these connected, yet disparate businesses.

He noted that Scaringe also “has the rare combination of being a truly great engineer while also having an exceptional instinct for product design,” said Fath, who previously worked at a major Rivian backer T.Rowe Price. “Very few founders can operate at that level technically while also understanding what resonates emotionally with customers — both consumers and commercial buyers. That combination is incredibly uncommon and has clearly been part of what makes Rivian’s products, and now Also and Mind’s, so differentiated.”

The pace of Scaringe’s fundraising over the past eight years is particularly notable, and doesn’t seem to be slowing.

More than $11 billion, and by far the largest slice of VC and strategic capital, went into Rivian — most of it between 2018 and its blockbuster IPO in 2021. That’s a startling timeline especially considering the company, initially called Mainstream Motors, had existed since 2009. For years, Rivian operated as a small, unknown entity until its breakout moment in late 2018 at the Los Angeles Auto Show, when it revealed prototypes of its all-electric R1T truck and R1S SUV.

The money soon flowed, and from every direction. In early 2019 and just a couple of months after that reveal, Rivian raised a $700 million funding round led by Amazon. U.S. automaker Ford would invest $500 million and make plans to collaborate on a since-scrapped future EV program. Cox Automotive contributed $350 million. Rivian would close out the year with a $1.3 billion round — its fourth in 2019 — led by funds and accounts advised by T. Rowe Price Associates, with additional participation from Amazon, Ford, and funds managed by BlackRock.

In July 2020, Rivian raised $2.5 billion and another $2.65 billion six months later. As whispers of an IPO got louder, Rivian closed another $2.5 billion private funding round led by Amazon’s Climate Pledge Fund, D1 Capital Partners, Ford Motor and funds and accounts advised by T. Rowe Price Associates Inc. Third Point, Fidelity Management and Research Company, Dragoneer Investment Group and Coatue also participated.

Then the IPO came. Rivian raised nearly $12 billion in gross proceeds after locking in $78 per share. Its market cap hit $100 billion when it debuted on Nasdaq in November 2021. Today, it stands at $18.2 billion today, a significant comedown that also reflects the broader struggles of the EV sector.

The ability to raise that much capital, despite those headwinds, is exceptional. But Scaringe didn’t stop with Rivian. If anything, the pace has accelerated. Also and Mind Robotics have together raised more than $1.3 billion so far, with Mind Robotics moving especially fast: $115 million in its first year, $500 million in March, and another $400 million just this week.

Rivian also continues to land notable backers through high-profile deals like the $5.8 billion joint venture with Volkswagen Group and a robotaxi partnership valued at up to $1.25 billion with Uber.

“Now, the big question is, how much can he do?” Behl said. “That’s a question [that] already assumes that he’s reaching his limit. The thing is, he doesn’t look at it that way. His perspective is that there is huge value to be created, there is huge impact to be created, and I just have to do it.”

When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

News

2027: I will withdraw as Atiku’s running mate, back Tinubu if petrol drops to N600 per litre

info

Published

on

Rotimi Amaechi.jpg

The Vice Presidential candidate of the African Democratic Congress, ADC, Rotimi Amaechi, has vowed to withdraw from the ticket of the party’s presidential candidate, Atiku Abubakar, if the price of petrol drops to N600 per litre by tomorrow.

Amaechi made the statement on Channels TV’s Politics Today on Friday while challenging the Federal Government’s claim that the cost of transportation and living expenses would decline following the reduction in fuel prices.

He questioned whether transportation costs from Nyanya to Abuja had reduced as promised, insisting that Nigerians were yet to feel the impact of the policies.

“Every day he repeats the same thing. He said by October 1, the price of transport would come down. Check the cost of transport from Nyanya to Abuja; has anything come down? Has anything changed?” he said.

Recommended

He added that if petrol sells for N600 per litre, he would campaign for President Bola Tinubu.

“If fuel has come down to N600 tomorrow, I will campaign for President Tinubu. If you doubt, come with your camera to my house in the morning. I will go to the filling station and buy fuel,” he said.

Amaechi further stated that he would withdraw as Atiku’s running mate and support Tinubu if the price of petrol reaches N600 per litre.

“If it comes down to N600, I, Chibuike Rotimi Amaechi, will withdraw as the Vice Presidential candidate of Atiku and campaign for President Tinubu,” he added.

Continue Reading

Health

Drug-resistant bacterial infections kill one million people annually – WHO

info

Published

on

WhatsApp Image 2026 05 18 at 21.41.48.jpeg

The World Health Organisation (WHO) says drug-resistant bacterial infections kill about one million people globally every year, calling for coordinated action across human, animal, food and environmental sectors to curb the growing threat.

Jean-Pierre Nyemazi, Acting Director of the AMR Department at WHO Headquarters, said this at a virtual media conference marking an exhibition at the European Parliament on AMR and its human impact.

The virtual conference preceded the exhibition, “AMR: The Human Stories Behind a Silent Pandemic,” being held at the European Parliament from 28 September to 2 October and featuring stories of people affected by AMR across Europe.

“AMR is taking many lives. One million people die every year due to drug-resistant bacteria alone – that is, two people every minute die of bacterial AMR,” Mr Nyemazi said.

He said the scale of deaths meant that AMR should no longer be treated as a “silent pandemic”, stressing that “we know what works” to prevent and control the threat.

“Preventing infections is the number one priority. This can be done through better vaccination, infection prevention and control, Water, Sanitation and Hygiene (WASH), and improved animal husbandry,” he said.

PT WHATSAPP CHANNEL
Dangote Refinery AD

“All of these work and can prevent AMR.”

Mr Nyemazi said strengthening surveillance, responsible use of antimicrobials, access to quality medicines and diagnostics, and reduction of environmental contamination could also make a difference.

“The tools exist, and the evidence is there, but the cost of inaction is rising. The longer we delay action, the higher the cost becomes,” he said.

He said the One Health approach, which recognises the links between human, animal, plant and environmental health, was essential because drug-resistant pathogens could move across sectors and borders.

According to him, parliamentarians have a critical role in ensuring that national AMR commitments are supported by legislation, financing and accountability.

“The media also plays an indispensable role. Journalists help bring AMR out of scientific circles and into public debate,” he said.

“They raise awareness, combat misinformation, and ensure that AMR remains visible to decision-makers and the public alike.”

He said WHO Member States approved an updated Global Action Plan on AMR at the World Health Assembly in May, providing a framework for combating AMR over the next 10 years through a One Health approach.

Mr Nyemazi said the updated plan placed stronger emphasis on prevention, governance, behavioural change and measurable targets, and that the four Quadripartite organisations developed it jointly.

He said the organisations comprised the Food and Agriculture Organisation (FAO), United Nations Environment Programme (UNEP), WHO and World Organisation for Animal Health (WOAH).

“What is new about the updated Global Action Plan on AMR for the next 10 years is that it is truly multi-sectoral – a genuine One Health plan.

“The previous plan was heavily focused on human health; this time the four Quadripartite organisations worked together and engaged all sectors,” he said.

Mr Nyemazi said a 10 per cent reduction in AMR was achievable through infection prevention and control, vaccination and improved access to quality antimicrobials, with better coordination, education and surveillance capable of delivering further gains.

He also called for investment in new antibiotics, antifungals, phage therapy and other technologies, while stressing the need to preserve existing medicines.

He said there was also a major access problem, with many regions unable to obtain even existing antibiotics.

A member of the European Parliament, Martin Häusling, said excessive antibiotic use in food-producing animals was contributing to the problem, particularly through mass treatment.

“When it comes to food-producing animals, we still use far too many last-resort antibiotics, and we must get away from that,” Mr Häusling said.

He said AMR was a global issue that could affect anyone, adding that it could destroy families and livelihoods.

To tackle it, the parliamentarian said it was important to create public awareness so that parliaments could address the issue properly, adding that the issue was still not taken as seriously as a future challenge should be.

Rob Purdie, an AMR survivor and member of the WHO Task Force of AMR Survivors, said his experience demonstrated the consequences of delayed diagnosis and treatment.

Mr Purdie said an infection that began with a headache eventually progressed to fungal meningitis after he received antibiotics for a condition that had not been properly diagnosed.

READ ALSO: Four Super Eagles stars who could decide Nigeria’s AFCON Qualifier against Guinea-Bissau

He said he eventually spent about $250,000 on hospital costs and had been unable to work for about five years.

“My ability to earn a living was eliminated for about five years in a single-income household where I provided for my wife and two children,” he said.

Mr Purdie said his experience underscored the need to keep AMR visible in public discussions.

“That is why it is so important for those of us who have survived and can speak, to remove the word ‘silent’ from the ‘silent pandemic’,” he said.

(NAN)


Discover more from Premium Times Nigeria

Subscribe to get the latest posts sent to your email.

Continue Reading

Trending